Primary Care Option for Hepatitis C Treatment Cost-Effective

Published November 17, 2013

Primary Care Option for Hepatitis C Treatment Cost-Effective
WASHINGTON, DC — The Extension for Community Healthcare Outcomes (ECHO) program, which trains primary care physicians to treat patients infected with hepatitis C in underserved communities, is cost-effective, a new analysis shows. "ECHO provides … Read more on Medscape

United States : IMBRUVICA (ibrutinib) Capsules Now Approved in the U.S. for …
Janssen Biotech, Inc. today announced the U.S. Food and Drug Administration (FDA) has approved IMBRUVICA (ibrutinib) capsules for the treatment of patients with mantle cell lymphoma (MCL) who have received at least one prior therapy. … Therapy … Read more on HispanicBusiness.com

Future Drug Policy to be Based in Equity, Health and Safety rather than Racism …
Hundreds of New Yorkers — students, cultural workers, academics, advocates, community organizers, young people, treatment providers, civil rights activists and others will break into small groups, to come up with solutions to a range of issues such as … Read more on eNews Park Forest

Marijuana laws in Washington, DC, poised to be relaxed
Washington, D.C., city council is considering a proposal to decriminalize possession of small amounts of the drug, and a majority of council members have signalled their support for the measure, including Mayor Vincent Gray, who has veto power … Read more on CBC.ca